• AEROSPACE

  • MINING

  • PHARMACEUTICALS

INTERVIEWS MORE INTERVIEWS

Recent acquisitions and investments have considerably enlarged Croda's presence in Brazil both in manufacturing and in R&D with its new innovation center at Campinas.
Merrimack Pharmaceuticals is focused on cancer treatment through a deeper understanding of cancer pathways and biological markers.
Spero Therapeutics is developing new antimicrobial drugs to substitute those that have become ineffectual as they meeting resistance.
"We work very closely with Pemex and are very confident in their ability."

ARTICLES

The Winning Formula: Building the Number One Biopharmaceutical Supercluster

February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.

Introducing Brazil's Chemical Sector

February 22, 2018
GBR investigates Brazil's chemical sector amidst a period of political and economic instability.

A Vote of Confidence in Mexico

January 31, 2018
Despite headwinds such as the NAFTA renegotiations, Mexico’s steel sector is seeing large investments by the likes of Ternium and ArcelorMittal, and is moving up the value chain, driven by a booming automotive sector.

Saskatchewan’s Mining Industry: Converting Potential into Success

January 31, 2018
Ranked the top destination for mineral exploration investment by the Fraser Institute in 2016, Saskatchewan has held strong ties to the mining sector for many years.

NEWS

GBR attends to Mining Indaba 2018

February 19, 2018
GBR attends to Mining Indaba 2018

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

THE OFFICIAL MINING IN AFRICA COUNTRY INVESTMENT GUIDE (MACIG) 2018

PARTNERS